Biomimetic Nanoplatform for Targeted Glioblastoma Therapy via Concurrently Triggering GPX4/DHODH Mediated Ferroptosis
Advanced Science · 2026-06 · 13 (31)
DOI: 10.1002/advs.202521236 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 23.03.2026. Verfasst von Guodong Ren und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Ferroptosis, Glioblastoma, Phospholipid Hydroperoxide Glutathione Peroxidase, Brain Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Research Fund of Shanxi Province Health Commission, Basic Research Plan Project of Shanxi Province.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM), the most aggressive and lethal type of brain cancer, is a considerable threat to human health. Conventional therapeutic modalities fail to yield satisfactory outcomes; therefore, a more effective intervention strategy is urgently required. Ferroptosis, a novel type of cell death, has potential for GBM therapy. However, its efficacy is substantially compromised by the tumor‐intrinsic anti‐ferroptosis defense system. Moreover, approaches that trigger ferroptosis by modulating a single target are insufficient. Thus, it is imperative to simultaneously inhibit anti‐ferroptotic regulators to overcome compensatory pathways and achieve robust tumor eradication. Therefore, in the present study, a multifunctional nanoplatform, hollow mesoporous manganese dioxide (H‐MnO 2 )‐hemin‐leflunomide@membrane ( MHL@M ), is proposed and fabricated. GBM cell membrane coating enables blood‐brain barrier (BBB) penetrating and tumor‐targeting properties. H‐MnO 2 consumes the overexpressed GSH in the tumor microenvironment (TME), and as derived Mn 2+ converts H 2 O 2 into more toxic •OH, resulting in a chemodynamic therapy (CDT) effect. Hemin downregulates glutathione peroxidase 4 (GPX4), and leflunomide inhibits dihydroorotate dehydrogenase (DHODH), which synergistically triggers ferroptosis. Both in vitro and in vivo results demonstrate that MHL@M has excellent tumor‐targeting, TME‐responsive, and ferroptosis activation capacities. This study provides a solid foundation for the development of ferroptosis‐based therapeutic strategies for GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Shanxi Medical University, Taiyuan, China.
- Shanxi Province Brain Degenerative Diseases Precision Diagnosis and Treatment Engineering Research Center, Shanxi Medical University, Jinzhong, China.
- State Key Laboratory of Flexible Electronics (LoFE) & Institute of Flexible Electronics (IFE), Northwestern Polytechnical University, Xi'an, China.
- Department of Neurosurgery, Shanxi Province Cancer Hospital/Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
- State Key Laboratory of Flexible Electronics (LoFE) & Institute of Flexible Electronics (IFE), Xiamen University, Xiamen, China.
ORCID-Profile: Lin Li
Förderung
- National Natural Science Foundation of China
- Research Fund of Shanxi Province Health Commission
- Basic Research Plan Project of Shanxi Province
- Shanxi Basic Research Program for Young Scientists
- Fujian Provincial Natural Science Foundation of China
- Ministry of Education of China
- Ministry of Education of the People's Republic of China
Zitieren
APA
Ren, G., Wang, X., Li, P., Wu, H., Bi, Z., Gao, Q., Ma, B., Tian, Z., Liu, J., Feng, F., Liu, W., Li, L., & Zhang, C. (2026). Biomimetic Nanoplatform for Targeted Glioblastoma Therapy via Concurrently Triggering GPX4/DHODH Mediated Ferroptosis. Advanced Science, 13(31). https://doi.org/10.1002/advs.202521236
Vancouver
Ren G, Wang X, Li P, Wu H, Bi Z, Gao Q, et al. Biomimetic Nanoplatform for Targeted Glioblastoma Therapy via Concurrently Triggering GPX4/DHODH Mediated Ferroptosis. Advanced Science. 2026;13(31). doi:10.1002/advs.202521236
BibTeX
@article{Ren2026,
author = {Ren, Guodong and Wang, Xuewei and Li, Panpan and Wu, Hao and Bi, Zhifei and Gao, Qi and Ma, Bolong and Tian, Zixuan and Liu, Jianfei and Feng, Fuqiang and Liu, Wen and Li, Lin and Zhang, Chengwu},
title = {Biomimetic Nanoplatform for Targeted Glioblastoma Therapy via Concurrently Triggering GPX4/DHODH Mediated Ferroptosis},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {31},
doi = {10.1002/advs.202521236}
}
EUVIMED